CellSave Arabia, the largest private stem cell biobank in the GCC and part of CSG.BIO, has signed an exclusive agreement with HMS Group in order to provide stem cell preservation services across its facilities.
Under this partnership, CellSave Arabia will serve as the exclusive provider of cord blood, cord tissue, placental tissue, cord vessel, and amnion preservation, integrating its services into HMS Group’s maternity care pathways.
Alia Abdel Razeq, COO of CellSave Arabia, said that, “This partnership marks a key step in advancing maternal and newborn healthcare standards in Dubai.”
CellSave Arabia will deliver end-to-end collection and storage services aligned with international standards, including AABB accreditation and ISO 20387 biobanking practices, ensuring high levels of safety and quality.
In addition to clinical services, the collaboration will include patient education initiatives such as antenatal sessions and awareness programs to support informed decision-making.
Alaa Attari, CEO at HMS Group, stated that, “We are pleased to partner with CellSave Arabia, a recognized leader in stem cell preservation and regenerative medicine. This collaboration reflects our commitment to providing expectant families with access to advanced healthcare solutions that help secure their future health and well-being. Together, we aim to raise awareness and support parents in making informed decisions throughout their maternity journey.”
According to the statement, this agreement underscores CellSave Arabia’s ongoing expansion and its strengthening position as a key player in advancing regenerative healthcare solutions across the UAE. It highlights the company’s commitment to driving innovation in the life sciences sector and supporting the growing demand for advanced, future-focused medical technologies in the region.
